Concord Health Partners, a Summit, NJ-based healthcare focused investment firm, closed Concord Innovation Fund II, at $150M.
Concord expanded its investor base with more than 50 Limited Partners, receiving support from pre-existing relationships and meaningful participation from both strategic and traditional investors, including RIAs, endowments, family offices and other institutions. The firm’s diverse LP base continues to strategically include a number of major provider organizations and payors as well as the American Hospital Association (the “AHA”), enabling Concord to work closely with its LPs to drive growth of its portfolio companies through accelerated adoption of innovative products and services.
Innovation Fund II builds on the firm’s strategy of investing in healthcare companies with innovative technologies and solutions that enhance the value of care through lower costs, improved quality and expanded access. Innovation Fund II focuses on growth stage investments.
To-date, more than 50% of the committed capital has been deployed across six portfolio companies, including Clarify Health, Loyal, Iris, Accelus and Mindmaze.
Led by James Olsen, Founder and Managing Partner, Concord established a second office in Nashville, which enhances its ability to identify, diligence and execute on opportunities in the region. Concord also added Erik Larsen and Derek Schmidt as Managing Directors based in Nashville, and announced on July 11 that Brian Gragnolati, who currently serves as President and CEO of Atlantic Health System and is former Chairman of the Board of Trustees of the American Hospital Association, joined the firm as Executive Partner.
Have a look at the team members here.
FinSMEs
19/09/2022